Whitehawk Therapeutics Files Q1 2025 10-Q
Ticker: WHWK · Form: 10-Q · Filed: May 8, 2025 · CIK: 1422142
| Field | Detail |
|---|---|
| Company | Whitehawk Therapeutics, INC. (WHWK) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financials
TL;DR
Whitehawk Therapeutics Q1 2025 10-Q filed. Financials updated.
AI Summary
Whitehawk Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Aadi Bioscience, Inc., is in the pharmaceutical preparations industry. Financial details for the quarter and prior periods are presented, including common stock and additional paid-in capital.
Why It Matters
This filing provides investors with an update on Whitehawk Therapeutics' financial position and operational activities for the first quarter of 2025, crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Whitehawk Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-08 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Whitehawk Therapeutics, Inc. (company) — Filer of the 10-Q
- Aadi Bioscience, Inc. (company) — Former name of Whitehawk Therapeutics
- 20250331 (date) — End of the reporting period
- 20250508 (date) — Filing date
FAQ
What is the primary business of Whitehawk Therapeutics, Inc.?
Whitehawk Therapeutics, Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
What was the previous name of Whitehawk Therapeutics, Inc.?
Whitehawk Therapeutics, Inc. was formerly known as Aadi Bioscience, Inc., with a name change date of 20210826.
What is the fiscal year end for Whitehawk Therapeutics, Inc.?
The fiscal year end for Whitehawk Therapeutics, Inc. is December 31.
What is the SEC file number for Whitehawk Therapeutics, Inc.?
The SEC file number for Whitehawk Therapeutics, Inc. is 001-38560.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Whitehawk Therapeutics, Inc. (WHWK).